Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dynamic hematological disease: a review.

Literature DB >> 18317766

Dynamic hematological disease: a review.

Abstract

We review the basic characteristics of four periodic hematological disorders (periodic auto-immune hemolytic anemia, cyclical thrombocytopenia, cyclical neutropenia and periodic chronic myelogenous leukemia) and examine the role that mathematical modeling and numerical simulations have played in our understanding of the origin of these diseases and in the regulation of hematopoiesis.

Entities: Disease

Mesh：

Year: 2008 PMID： 18317766 DOI： 10.1007/s00285-008-0165-3

Source DB: PubMed Journal: J Math Biol ISSN： 0303-6812 Impact factor: 2.259

76 in total

1. Oscillations in cyclical neutropenia: new evidence based on mathematical modeling.

Authors: Samuel Bernard; Jacques Bélair; Michael C Mackey
Journal: J Theor Biol Date: 2003-08-07 Impact factor: 2.691

2. Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor.

Authors: R Hoffman; R A Briddell; K van Besien; E F Srour; T Guscar; N W Hudson; A Ganser
Journal: N Engl J Med Date: 1989-07-13 Impact factor: 91.245

Review 3. Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.

Authors: C Haurie; D C Dale; M C Mackey
Journal: Blood Date: 1998-10-15 Impact factor: 22.113

4. A mathematical model of neutrophil production and control in normal man.

Authors: S I Rubinow; J L Lebowitz
Journal: J Math Biol Date: 2017-03-15 Impact factor: 2.259

5. A study of the interdependence of red cell and bone marrow stem cell populations.

Authors: J S Orr; J Kirk; K G Gray; J R Anderson
Journal: Br J Haematol Date: 1968-07 Impact factor: 6.998

6. Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: potential mechanisms for survival enhancing effects.

Authors: A Ritchie; A Gotoh; J Gaddy; S E Braun; H E Broxmeyer
Journal: Blood Date: 1997-12-01 Impact factor: 22.113

7. The effect of continuous G-CSF application in human cyclic neutropenia: a model analysis.

Authors: S Schmitz; H Franke; H E Wichmann; V Diehl
Journal: Br J Haematol Date: 1995-05 Impact factor: 6.998

8. Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function.

Authors: C L Balduini; C C Stella; V Rosti; G Bertolino; P Noris; E Ascari
Journal: Br J Haematol Date: 1993-12 Impact factor: 6.998

9. New TPO treatment schedules of increased safety and efficacy: pre-clinical validation of a thrombopoiesis simulation model.

Authors: Kirill Skomorovski; Hila Harpak; Anton Ianovski; Moshe Vardi; Trudi P Visser; Simone C C Hartong; Huub H D M van Vliet; Gerard Wagemaker; Zvia Agur
Journal: Br J Haematol Date: 2003-11 Impact factor: 6.998

Dynamic hematological disease: a review.

1. Oscillations in cyclical neutropenia: new evidence based on mathematical modeling.

2. Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor.

Review 3. Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.

4. A mathematical model of neutrophil production and control in normal man.

5. A study of the interdependence of red cell and bone marrow stem cell populations.

6. Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: potential mechanisms for survival enhancing effects.

7. The effect of continuous G-CSF application in human cyclic neutropenia: a model analysis.

8. Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function.

9. New TPO treatment schedules of increased safety and efficacy: pre-clinical validation of a thrombopoiesis simulation model.

10. A mathematical model of erythropoiesis in mice and rats. Part 1: Structure of the model.

1. Analysis of unstable behavior in a mathematical model for erythropoiesis.

2. Structured models of cell migration incorporating molecular binding processes.

3. Normal and pathological dynamics of platelets in humans.

4. Dynamic spatial pattern formation in the sea urchin embryo.

5. Understanding, treating and avoiding hematological disease: better medicine through mathematics?

6. Response of an oscillatory differential delay equation to a single stimulus.

7. The impact of CD34+ cell dose on engraftment after SCTs: personalized estimates based on mathematical modeling.

8. Transit and lifespan in neutrophil production: implications for drug intervention.

9. Response of an oscillatory differential delay equation to a periodic stimulus.

Review 10. The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.